Navigation Links
ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders
Date:9/6/2010

treated patients (p=0.000003). Epiretinal membrane is a layer of scar tissue which builds up on the macula, making it more difficult to achieve resolution of VMA without surgical intervention. Epiretinal membrane can be easily identified using Optical Coherence Tomography (OCT).

The MIVI-TRUST program's pooled results also highlighted microplasmin's impressive effect in patients diagnosed with FTMH. In this group, 40.6% of the 106 patients saw closure of their FTMH at 28 days following a single 125micro-g injection of microplasmin without the need for a vitrectomy. This compares with 10.6% of the 47 patients in the placebo group (p= 0.00015). The closure of FTMH also led to microplasmin treated patients experiencing a significant improvement in their visual acuity (VA) compared to baseline.

Prof. Stalmans also presented an analysis of the pooled visual acuity data from the Phase III program. This showed that at the end of the six month study period, 23.7% of the microplasmin treated patients had achieved at least a 10 letter (2 lines) improvement in VA without the need for vitrectomy. This compares to only 11.2% of the patients who received a placebo injection (p=0.0002). Within the microplasmin treated population, 9.7% of patients achieved a 15 letter (3 lines) improvement in their visual acuity without the need for vitrectomy, compared to just 3.7% of the placebo patients (p=0.01). In addition, microplasmin treated patients showed an improved Quality of Life when compared to placebo, based on the VFQ-25 (the National Eye Institute Visual Functioning Questionnaire) results.

The pooled results also confirmed that microplasmin was generally safe and well tolerated. There was no evidence of an increased risk of retinal tear or detachment.

Dr. Patrik De Haes, CEO of ThromboGenics, commented, "The successful completion and reporting of our 652 patient Phase III program with microplasmin in just 20 months demonstrates ThromboGenics' highl
'/>"/>

SOURCE ThromboGenics NV
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
2. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
3. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
4. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
5. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
6. ThromboGenics Microplasmin Phase III Program Progressing According to Schedule
7. ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402
8. ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
9. ThromboGenics and BioInvent Complete Patient Recruitment of Phase II DVT Prophylaxis Study With Anti-Factor VIII (TB-402)
10. ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
11. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)...  Medical Science Liaisons serve as a critical bridge ... sector. As the impact of technology in the marketplace ... Science Liaisons (MSLs) interact with physicians and other thought ... to not only share important disease and therapy information ... interactions across geographies and therapeutic areas. While ...
(Date:8/22/2014)... August 22, 2014 ... ) has announced the addition of the  ... to their offering.       (Logo: ... essential instrument for any modern science laboratory ... of materials. It can be broadly classified ...
(Date:8/22/2014)... , August 22, 2014 ... announced the addition of the  "Global Operating ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... a sterile environment in a healthcare facility ... equipped with technically advanced equipment, which ensures ...
Breaking Medicine Technology:iPads Enhancing Medical Science Liaison Interactions with Thought Leaders, New Study Shows 2Global Laboratory Electronic Balance Market 2014-2018: Key Vendors are A&D Company, Mettler-Toledo, Sartorius and Thermo Fisher 2Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2
... 2012   OphthaliX (OTCBB: OPLI) today reported its ... 31, 2012. OphthaliX is an advanced clinical-stage biopharmaceutical company ... ophthalmic disorders.  Our drug, CF101 (known generically as IB-MECA), ... eye syndrome; glaucoma and uveitis. We are currently: (i) ...
...  Fluke Biomedical announced today the newest addition to ... and troubleshooting tools, the SPOT Light SpO2 ... maintenance (PM) test for SpO2 patient monitor functionality, ... SpO2 functional tester ever achieved by this industry-leading ...
Cached Medicine Technology:OphthaliX Reports First Quarter 2012 Financial Results 2OphthaliX Reports First Quarter 2012 Financial Results 3Fluke Biomedical launches speedy new ProSim™ SPOT Light SpO2 Functional Tester 2
(Date:8/22/2014)... 23, 2014 Search Engine Optimization ... first page of search engines and get more ... has recently compared many Linux hosting suppliers and ... are the most recommended Linux hosting suppliers for ... Europe to buy high quality Linux hosting (including ...
(Date:8/22/2014)... 2014 The IT manager of Top10BestSEOHosting.com ... for several years. He has recently announced that GoDaddy ... suppliers in 2014. , GoDaddy is a popular supplier ... and great hosting solutions at affordable rates. It offers ... shared hosting plans depend on the length of the ...
(Date:8/22/2014)... 23, 2014 2014 Deep Research ... professional and in-depth research report on the Glucose ... information, including Glucose Meter definition, classification, application, and ... This research covers the international market analysis, including ... covering macroeconomic environment & economic situation analysis. The ...
(Date:8/22/2014)... 22, 2014 On Friday, Aug. 22, ... and Health Sciences , hosting a ceremony in its ... in government and public welfare. , The 162-member inaugural ... Medicine (LUCOM) joined Liberty staff, faculty, and community ... of the new medical school. Classes began on Monday, ...
(Date:8/22/2014)... Recently, Skmen.com, an experienced supplier of fashionable clothes, ... in its online store. Moreover, all these excellent items ... off. All the international clients can obtain these ... , The company’s professional online workers update its product ... more the latest information about its new arrivals and ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Announces Best Cheap Hosting Suppliers Of This Summer 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 4Health News:Cheap Bohemian Dresses Unveiled by Experienced Supplier Skmen.com 2
... , MONDAY, April 9 (HealthDay News) -- People ... problems, such as ulcers and bleeding, and also for ... The findings highlight the need to develop new ... arthritis patients, according to the Mayo Clinic researchers. ...
... than 60 percent of breast cancer survivors report at ... diagnosis, according to a new study led by a ... University of Pennsylvania. The findings are part of a ... late effects of breast cancer treatment and creating strategies ...
... , MONDAY, April 9 (HealthDay News) -- Hispanics and ... and Medicare and Medicaid patients are less likely to receive ... says. University of Michigan School of Public Health researchers ... were 1.5 times more likely to receive antidepressants than blacks ...
... , (WASHINGTON, April 9, 2012) A novel anti-leukemia compound with ... (T-ALL), suggesting its potential to become a new highly targeted ... according to results from a study published ... of the American Society of Hematology (ASH). ...
... 262 Pages | $29.95 | ISBN13: 9780199892594) "Roberta Ness teaches how ... as its subject, Dr. Ness shows how, with a little know-how and ... selves.", ... Medicine, National Academies of Science "Great science depends on innovative ...
... in-patient rehabilitation are more likely to land back in ... poorly, show signs of depression and lack social support ... Branch (UTMB) at Galveston. Hospital readmission for older adults ... billion annually. , Among the first of such ...
Cached Medicine News:Health News:Gastro Woes Often Strike Rheumatoid Arthritis Patients 2Health News:Breast cancer patients suffer treatment-related side effects long after completing care 2Health News:Breast cancer patients suffer treatment-related side effects long after completing care 3Health News:Minorities, Medicare Recipients Less Likely to Get Antidepressants 2Health News:Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment 2Health News:Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment 3Health News:Innovation Generation 2Health News:Innovation Generation 3Health News:Predictors identified for rehospitalization among post-acute stroke patients 2Health News:Predictors identified for rehospitalization among post-acute stroke patients 3
... CS makes the outstanding ... CS even more flexible. ... Technologies, the Wireless Propaq ... ethernet Local Area Networks ...
... Welch Allyn Vital Signs Monitor ... clinical areas that don't require ... to use, each monitor comes ... and optional features include Nellcor ...
... Propaq CS offers the features needed for ... large 8.4-inch TFT color display allows you ... two vectors of ECG. The touch screen ... not impaired by gloves or temperature., ...
... The Mobile Acuity LT Central Monitoring Station ... Medical Delivery Area when and where it's ... immediately on-site in response to emergency situations ... care for victims involved., ,Used in ...
Medicine Products: